
Stock·NASDAQ·Financial Services
MarketAxess Holdings Inc. (MKTX)
- Market cap
- $5.82B
- P/E
- 20.26
- Dividend yield
- 1.88%
- Street target
- $167.00median of 12 analysts
- 52-week range
- $108.75 $195.97
MKTX stock today, November 12, 2026: price, news and analyst targets
As of November 11, 2026, MarketAxess Holdings Inc. (MKTX) trades at $165.31. Wall Street's median 12-month price target is $167.00 across 12 analysts, 1.0% above the price. CleaRank rates it Buy with a score of 61/100.
MarketAxess is trading near the middle of its 52-week range at $165.31, above its 20-day, 50-day and 200-day averages, and the stock is still the subject of a steady stream of cautious analyst ratings. The company's most recent quarter, reported on October 23, 2026, produced adjusted EPS of $1.86, a 4.62% miss against the $1.95 estimate, yet the shares rose 0.21% in the next session. Revenue shrank year on year in that quarter, which sets up a tension for investors between a strong profit profile and slowing top-line growth.
Earnings: a small miss and a muted reaction
MarketAxess reported adjusted EPS of $1.86 on October 23, 2026, against an analyst estimate of $1.95, a miss of 4.62%. It was only the second miss in the seven most recent reports, and the six beats before it were modest, ranging from 2.44% to 4.84% above estimates. The shares rose 0.21% in the first session after the report, so the market did not treat the shortfall as a major setback. Over the same seven reports, four beats were followed by a lower share price, which suggests that the price reaction to earnings has been less consistent than the beat rate alone would imply.
Revenue is the weak point
Revenue shrank in the latest quarter compared with the same quarter a year earlier, a decline of 0.48%. Analysts still expect revenue to rise 5.1% this fiscal year to $889.1M, so the forecast assumes a turnaround from the latest quarter. The contrast is important: the business earns a net profit margin of 33.5%, and its return on equity of 21.85% is above the sector median of 13.8%, but profits are being generated from a sales base that is not currently growing.
A premium valuation
At a trailing P/E of 20.26, the stock trades 22.8% above the sector median of 16.5, and its price-to-sales ratio of 6.68 is 75.8% above the sector median of 3.8. Those premiums are the main reason the valuation factor weighs against the stock in CleaRank's score. The price is paying for profitability and a balance sheet with a debt-to-equity ratio of 0.12, but it is not paying for fast revenue growth, which is the ingredient that would normally justify a premium of this size.
Analysts are cautious rather than negative
All 12 analysts with a current rating hold the stock, and none rate it buy or sell. Three months earlier one analyst rated it a buy out of 12. Recent actions have been mostly reiterations, with Morgan Stanley keeping its Equal-Weight rating on October 9, 2026, but UBS downgraded the stock to Neutral from Buy on July 31, 2026 and Keefe, Bruyette & Woods cut it to Market Perform from Outperform on August 11, 2026. Insider activity has been one-directional: 16 sales worth $2.5M over the last 18 months, with no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying.
CleaRank score 61/100 (Buy). 12 of 19 checks pass: trend 4 of 4, momentum 3 of 3, valuation and quality 3 of 5, analysts 1 of 3, track record 1 of 4.
About MarketAxess Holdings
MarketAxess Holdings Inc. is a financial technology and market infrastructure company that operates an electronic trading platform for institutional investors and broker-dealers. S. government bonds. Its product suite also includes automated and algorithmic trading tools, data and analytics offerings, and post-trade services such as trade matching, publication, and regulatory reporting. A key feature of the business is its all-to-all Open Trading model, which connects market participants directly and supports liquidity in credit markets.
MKTX stock news
Small EPS miss, muted reaction
·Earnings report
Adjusted EPS of $1.86 fell 4.62% short of the $1.95 estimate on October 23, 2026, yet the shares rose 0.21% in the next session. The market appears to have looked past the miss, but future misses would test that tolerance.
Downgrade from UBS
·UBS
UBS downgraded the stock to Neutral from Buy on July 31, 2026. The move removed one of the bullish voices on the Street and is part of why no analyst now rates the stock a buy.
Keefe, Bruyette & Woods cuts to Market Perform
·Keefe, Bruyette & Woods
Keefe, Bruyette & Woods downgraded the stock to Market Perform from Outperform on August 11, 2026. The cut followed the UBS move within a few weeks and adds to the pressure on the rating split.
Morgan Stanley keeps Equal-Weight
·Morgan Stanley
A reiteration signals that the firm sees neither a clear upside nor a clear downside at current prices.
Barclays keeps Equal-Weight
·Barclays
Barclays kept its Equal-Weight rating on August 10, 2026. Repeated neutral ratings from large banks suggest the Street is waiting for evidence that revenue growth can return before changing its view.
MKTX price target 2026
The base case is that MarketAxess holds its gains while the market weighs its profitability against slower sales. The company's operating margin of 41.19% and return on equity of 21.85% give it room to absorb a soft revenue quarter, and analysts expect EPS to grow 6.0% this year to $7.84 and 10.9% next year to $8.69. Those forecasts depend on revenue returning to growth, since analysts expect revenue to rise 5.1% this year to $889.1M. The median 12-month analyst target is $167.00, only 1.0% above the price, and the lowest target is $124.00. Upside beyond the target would need evidence that revenue growth is recovering, which the most recent quarter did not show. A further earnings miss or a sustained fall below the 50-day average would weaken the case, because the stock already trades at a premium to peers on earnings and sales.
Analyst targets and ratings
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Aug 11, 2026 | Keefe, Bruyette & Woods | Downgrade | Market Perform |
| Aug 10, 2026 | Barclays | Maintains | Equal-Weight |
| Jul 31, 2026 | UBS | Downgrade | Neutral |
| Jul 15, 2026 | Piper Sandler | Maintains | Neutral |
| Jul 10, 2026 | Morgan Stanley | Maintains | Equal-Weight |
MKTX support and resistance levels
Support sits first at the 20-day EMA of $165.04, which the price is only just above, so it is a near-term reference rather than a cushion. The next support is the 50-day SMA at $164.26, followed by the 200-day SMA at $155.05, which the stock has held above. The 52-week low of $108.75 is the furthest support. On the upside, the nearest resistance is the 52-week high of $195.97, which a rise would meet first. The analysts' median target of $167.00 sits just above the price and may act as a psychological ceiling for now.
| Level | What it is | Price | From the price |
|---|---|---|---|
| Resistance 1 | 52-week high | $195.97 | +18.5% |
| Price | November 11, 2026 | $165.31 | |
| Support 1 | 20-day exponential average | $165.04 | -0.2% |
| Support 2 | 50-day moving average | $164.26 | -0.6% |
| Support 3 | 200-day moving average | $155.05 | -6.2% |
| Support 4 | 52-week low | $108.75 | -34.2% |
Technical indicators
MKTX stock price and trading
MKTX share price
MKTX fundamentals and valuation
Key statistics
MKTX against the Financial Services sector
Price to earnings vs sector: MKTX trades at a significant premium to sector peers (+23% against the sector median P/E). Investors are paying more for each dollar of earnings than for the typical stock in the sector.
Return vs XLF: Since Jun 2, 2025, MKTX has lost 24.5% against a gain of 15.0% for XLF.
Performance against XLF
Revenue and earnings
Revenue growth: Revenue grew 3.6% in FY2025 to $846M, from $817M a year earlier.
Profit margin: The net margin was 29.2% in FY2025, down from 33.6% the year before.
Profitable: MKTX earned $247M in FY2025.
Earnings reality check
Earnings record: MKTX beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 23, 2026 | $1.95 | $1.86 | -4.62% | +0.21% | +0.38% |
| Jul 30, 2026 | $1.86 | $1.95 | +4.84% | -0.28% | -0.09% |
| May 7, 2026 | $2.15 | $2.25 | +4.65% | -3.36% | -7.96% |
| Feb 6, 2026 | $1.64 | $1.68 | +2.44% | +5.48% | +10.49% |
| Nov 7, 2025 | $1.70 | $1.84 | +8.24% | +1.15% | +4.60% |
| Aug 6, 2025 | $1.96 | $2.00 | +2.04% | -1.27% | +1.18% |
| May 7, 2025 | $1.81 | $1.87 | +3.31% | -0.83% | -7.59% |
MKTX price history and drawdowns
Risk profile
Worst falls and recoveries
Growth of $10,000
Against the market: MKTX trailed the S&P 500 over this period: $11,232 against $40,494.
A $10,000 investment in MKTX in December 2016 would be worth about $11,232 today with dividends reinvested, compared with about $40,494 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
MKTX stock price prediction 2030
MKTX Stock Price Prediction 2030: Simulated Scenarios
CleaRank's simulation projects a price near $187 for MKTX by 2030 in the base case, from $165 today (1.1x over 4 years). The 10th-percentile path ends near $78.76. These are outcomes of a Monte Carlo simulation run on MKTX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $111 | $170 | $263 | |
| 2028 | $95.40 | $176 | $324 | |
| 2029 | $85.75 | $181 | $383 | |
| 2030 | $78.76 | $187 | $444 |
MKTX insider trading
MKTX insider trading
Month by month
Net insider selling: No insider bought MKTX shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Scott Pintoff
General Counsel
|
Sell | 100 | $16.5K |
| Sep 10, 2026 | William Frank Cruger Jr
Director
|
Sell | 6.2K | $1.0M |
| Sep 10, 2026 | Scott Pintoff
General Counsel
|
Sell | 100 | $16.3K |
| Aug 12, 2026 | Emily Hope Portney
Director
|
Grant | 2.1K | - |
| Aug 10, 2026 | Scott Pintoff
General Counsel
|
Sell | 100 | $16.3K |
| Aug 7, 2026 | Jane P Chwick
Director
|
Grant | 606 | - |
| Jul 10, 2026 | Scott Pintoff
General Counsel
|
Sell | 100 | $11.5K |
| Jun 18, 2026 | Carlos Mauricio Hernandez
Director
|
Grant | 10.7K | - |
| Jun 10, 2026 | Scott Pintoff
General Counsel
|
Sell | 100 | $11.6K |
| Jun 10, 2026 | Nancy A. Altobello
Director
|
Grant | 1.4K | - |
MKTX stock forecast: questions people ask
MKTX Forecast: Frequently Asked Questions
What is the MKTX stock forecast?
What is the MKTX price target?
Is MKTX a buy or sell today?
How did MarketAxess perform over the past year?
Is MarketAxess expensive compared with its sector?
Does MarketAxess pay a dividend?
How fast is MarketAxess expected to grow its earnings?
How these figures are computed, and where the data comes from: CleaRank methodology.